Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth
The availability of nutrients within the tumour microenvironment can influence tumour growth. Here, the authors find that, in a melanoma mouse model, mice fed a high glutamine diet have reduced tumour growth, increased sensitivity to Braf inhibitors and elevated a-ketoglutarate levels.
Guardado en:
Autores principales: | Mari B. Ishak Gabra, Ying Yang, Haiqing Li, Parijat Senapati, Eric A. Hanse, Xazmin H. Lowman, Thai Q. Tran, Lishi Zhang, Linda T. Doan, Xiangdong Xu, Dustin E. Schones, David A. Fruman, Mei Kong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f55f7d0478ab4cf7851235354cd349ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1
por: Ying Yang, et al.
Publicado: (2019) -
Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
por: Yujun Hao, et al.
Publicado: (2016) -
Sequence features of retrotransposons allow for epigenetic variability
por: Kevin R Costello, et al.
Publicado: (2021) -
A Critical Role of Glutamine and Asparagine γ-Nitrogen in Nucleotide Biosynthesis in Cancer Cells Hijacked by an Oncogenic Virus
por: Ying Zhu, et al.
Publicado: (2017) -
Epigenetic modulation reveals differentiation state specificity of oncogene addiction
por: Mehwish Khaliq, et al.
Publicado: (2021)